Interlux NT - Company finances
|
EUR
|
2018
From: 2018-02-09
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 75,976 | 87,193 | 89,830 | 90,185 | 92,983 | 94,365 | 108,768 | 217,002 |
| Profit before tax | 13,287 | 3,014 | 686 | 2,626 | -32,942 | -155,430 | -24,479 | 5,551 |
| Net profit | 11,294 | 227 | -695 | 983 | -32,918 | -155,430 | -24,479 | 5,551 |
| Equity | 2,282,550 | 2,282,364 | 2,281,669 | 2,282,652 | 2,249,734 | 2,094,304 | 2,069,825 | 2,075,373 |
| Liabilities | 20,424 | 5,010 | 110,026 | 105,057 | 153,381 | 930,569 | 2,024,945 | 2,150,033 |
| Non-current assets | 1,315,515 | 1,268,032 | 1,219,665 | 1,327,522 | 1,421,205 | 2,142,328 | 3,145,577 | 3,302,874 |
| Current assets | 986,756 | 1,019,342 | 1,172,030 | 956,397 | 969,670 | 882,865 | 949,251 | 922,742 |
| Total assets | 2,302,271 | 2,287,374 | 2,391,695 | 2,283,919 | 2,390,875 | 3,025,193 | 4,094,828 | 4,225,616 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 25,177 | 14,046 | 2,634 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | +14.8% | +3.0% | +0.4% | +3.1% | +1.5% | +15.3% | +99.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.5% | 0.0% | 0.0% | 0.0% | -1.4% | -5.1% | -0.6% | 0.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.5% | 0.0% | 0.0% | 0.0% | -1.5% | -7.4% | -1.2% | 0.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 14.9% | 0.3% | -0.8% | 1.1% | -35.4% | -164.7% | -22.5% | 2.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 17.5% | 3.5% | 0.8% | 2.9% | -35.4% | -164.7% | -22.5% | 2.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.4 | 1.0 | 1.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 75,976 | 87,193 | 89,830 | 90,185 | 92,983 | 49,233 | 54,384 | 108,501 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Interlux NT - Social security debts
The company had no debts to Sodra
Interlux NT - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-01-29 | 2026-01-30 | 0.63 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Interlux NT, UAB (code 304764863) is a Private Limited Liability Company operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated €217.0K in revenue, up 99.5% year on year and 130.0% over two years. Profitability improved materially: net profit turned positive at €5.6K in 2025 after a €24.5K loss in 2024 and a €155.4K loss in 2023. The 2025 profit margin was 2.6%, compared with negative margins in the previous two years. The balance sheet remained sizeable, with total assets of €4.23M, equity of €2.08M and liabilities of €2.15M at the end of 2025. Long-term assets accounted for most of the asset base at €3.30M, while short-term assets were €922.7K. Key efficiency and return indicators were modest in 2025, with ROE at 0.3%, ROA at 0.1% and asset turnover at 0.05x. Debt-to-equity stood at 1.04, and revenue per employee was €108.5K, indicating limited profitability despite higher sales.